| Detected | Trial | Change |
|---|---|---|
| 2026-05-27 | NCT07214779 Study to Evaluate INCB123667 Versus Investigator's Choice of Chemotherapy in Participants… |
Trial sites expanded: 162 -> 165 locations |
| 2026-05-27 | NCT07023627 A Study of INCB123667 in Participants With Platinum-Resistant Ovarian Cancer With Cyclin… |
Trial sites reduced: 82 -> 79 locations |
| NCT ID | Title | Condition | Status |
|---|---|---|---|
| Phase 3 | |||
| NCT07214779 | Study to Evaluate INCB123667 Versus Investigator's Choice of Chemotherapy in Participants… | Ovarian Cancer | Recruiting |
| Phase 2 | |||
| NCT07023627 | A Study of INCB123667 in Participants With Platinum-Resistant Ovarian Cancer With Cyclin… | Ovarian Cancer | Recruiting |
| Phase 1 | |||
| NCT06909162 | A Study to Evaluate the Effect of Food on the Single-Dose Pharmacokinetics and a… | Healthy Participants | Recruiting |
| NCT07559396 | A Study to Assess the Safety and Pharmacokinetics of INCB123667 When Administered Orally… | Renal Impairment | Not Yet Recruiting |
| NCT07559474 | A Study to Assess the Safety and Pharmacokinetics of INCB123667 When Administered Orally… | Hepatic Insufficiency | Not Yet Recruiting |